drugset / Trial / NCT02424149

Phenazopyridine for Confirmation of Ureteral Patency

NCT02424149

Completed 107 enrolled Hartford Hospital
RandomizedParallel-groupOpen-labelDiagnostic

Summary

In this prospective, randomized trial subjects will be randomized to receive phenazopyridine or no medication prior to pelvic reconstructive procedures that use cystoscopy to confirm ureteral patency intraoperatively.

Timeline

Start
2015-04
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenazopyridine Small molecule

Indications

No indication recorded.